Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction.
Gurbel
P A
PA
Dalesandro
M R
MR
Serebruany
V L
VL
D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy*; D019007:P-Selectin / Q000097:blood*; D010960:Plasminogen Activators / Q000494:pharmacology* / Q000627:therapeutic use; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000097:blood*; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000494:pharmacology* / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D019007:P-Selectin; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D011994:Recombinant Proteins; C087896:reteplase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator